Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis
- PMID: 31250167
- DOI: 10.1007/s00330-019-06302-9
Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis
Abstract
Objective: To study a muscle-to-muscle standardised uptake value (SUV) ratio with FDG-PET/CT (FDG-PET) as a marker for the detection of disease activity in dermatomyositis (DM).
Methods: Patients with DM (n = 24) who met the European Neuro-Muscular Centre diagnostic criteria were retrospectively identified over a 3-year period through a national survey. Muscle biopsy was performed in all patients. Maximum SUV was measured in proximal muscles (SUVPROX) that had the highest radiotracer uptake on visual grading as well as in the musculus longissimus thoracis (SUVMLT), whereas mean SUV was measured for the liver (SUVLIV). Muscle-to-liver SUV ratios for either muscle group were compared and a SUVPROX/SUVMLT ratio was calculated. SUVPROX/SUVMLT of DM patients were compared with age- and sex-matched control subjects (n = 24) with melanoma who had received FDG-PET scans.
Results: DM patients presented with proximal and symmetrical muscle uptake. Differences in SUVPROX/SUVLIV and SUVMLT/SUVLIV ratios in DM subjects were significant (p < 0.001). SUVPROX/SUVMLT ratios in DM and their controls also differed significantly (p = 0.0012). The SUVPROX/SUVMLT ratio threshold between DM subjects and controls was 1.73 with a sensitivity of 50% (CI95%, 29.1 to 70.9%) and specificity at 83.3% (CI95%, 62.6 to 95.3%). When amyopathic DM patients were removed from the analysis, specificity was increased to 95% (CI95%, 75.1 to 99.9%) with a likelihood ratio of 10 and an AUC of 83.4% (CI95%, 71.4 to 95.4%).
Conclusion: A muscle-to-muscle SUVPROX/SUVMLT ratio with a cut-off value of 1.73 in FDG-PET imaging might serve as a non-invasive marker to determine disease activity in dermatomyositis.
Key points: • [18F]-FDG PET-scanner standardised uptake value (SUV) could reflect disease activity in dermatomyositis (DM). • A ratio of SUV in proximal muscles (SUVPROX) to SUV in musculus longissimus thoracis (SUVMLT) could be used to determine active DM. • Active disease is suspected for SUV PROX /SUV MLT ratios greater than 1.73.
Keywords: Amyopathic dermatomyositis; Dermatomyositis; Fluorodeoxyglucose F18; Myositis; Positron-emission tomography.
Similar articles
-
[The application of (18)F fluorodeoxyglucose-positron emission tomography/computed tomography in the diagnosis and treatment of dermatomyositis].Zhonghua Nei Ke Za Zhi. 2016 Jul 1;55(7):525-30. doi: 10.3760/cma.j.issn.0578-1426.2016.07.008. Zhonghua Nei Ke Za Zhi. 2016. PMID: 27373287 Chinese.
-
[18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.Rheumatology (Oxford). 2013 Jul;52(7):1271-8. doi: 10.1093/rheumatology/ket112. Epub 2013 Mar 11. Rheumatology (Oxford). 2013. PMID: 23479721
-
Clinical value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis.J Dermatol. 2019 Mar;46(3):213-218. doi: 10.1111/1346-8138.14758. Epub 2019 Jan 4. J Dermatol. 2019. PMID: 30614031
-
Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.Radiographics. 2016 Mar-Apr;36(2):481-96. doi: 10.1148/rg.2016150102. Radiographics. 2016. PMID: 26963458 Review.
-
18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis.J Hepatol. 2019 Jul;71(1):115-129. doi: 10.1016/j.jhep.2019.01.038. Epub 2019 Feb 21. J Hepatol. 2019. PMID: 30797051
Cited by
-
Muscle Function, Muscle Disease, and Positron Emission Tomography-Computed Tomography: A Narrative Review.Cureus. 2025 Feb 28;17(2):e79857. doi: 10.7759/cureus.79857. eCollection 2025 Feb. Cureus. 2025. PMID: 40166518 Free PMC article. Review.
-
MRI and muscle imaging for idiopathic inflammatory myopathies.Brain Pathol. 2021 May;31(3):e12954. doi: 10.1111/bpa.12954. Brain Pathol. 2021. PMID: 34043260 Free PMC article. Review.
-
The Role of Quantitative and Semi-quantitative [18F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis.Front Med (Lausanne). 2022 Apr 15;9:883727. doi: 10.3389/fmed.2022.883727. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492313 Free PMC article. Review.
-
[18F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort.Diagnostics (Basel). 2023 Jul 8;13(14):2316. doi: 10.3390/diagnostics13142316. Diagnostics (Basel). 2023. PMID: 37510060 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous